Literature DB >> 12168790

GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis.

M Korabiowska1, C Cordon-Cardo, H Betke, T Schlott, M Kotthaus, J Stachura, U Brinck.   

Abstract

The main role of growth arrest and DNA damage-inducible (GADD) genes is to block proliferation at G1 and G2 checkpoints in response to DNA damage. The goal of this study was to examine the expression of GADD genes in primary melanomas with respect to prognosis. GADD34 was found in 73% of the primary melanomas investigated. GADD45 and GADD153 were positive in 60% and 80% of primary melanomas, respectively. Cox regression demonstrated that only GADD153 had any independent prognostic impact. We therefore decided to establish a PCR assay for detection of GADD153 in paraffin-embedded tissue. GADD153 deletion was found in 3/26 melanomas. None of the 3 cases with GADD153 deletion showed any expression of GADD153. Sequencing analysis detected polymorphism T-C at amino acid position 10 in 6/23 melanomas. In 6 cases with GADD153 polymorphism, GADD153 expression was found in 2 melanomas with a maximum GADD153 index of 10%. We postulate that the GADD gene family plays an important role in melanoma progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168790     DOI: 10.14670/HH-17.805

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

1.  Clinical significance of GADD153 expression in stage I non-small cell lung cancer.

Authors:  Chang Youl Lee; Myung Goo Lee; Kyung Chan Choi; Hee Mo Kang; Yoon Soo Chang
Journal:  Oncol Lett       Date:  2012-06-21       Impact factor: 2.967

Review 2.  Melanoma biomarkers: current status and vision for the future.

Authors:  Allison R Larson; Eliz Konat; Rhoda M Alani
Journal:  Nat Clin Pract Oncol       Date:  2008-12-23

Review 3.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

4.  C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.

Authors:  Sanjay Anand; John Ebner; Christine B Warren; Manu S Raam; Melissa Piliang; Steven D Billings; Edward V Maytin
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

5.  Expression of CHOP in squamous tumor of the uterine cervix.

Authors:  Hyun Hee Chu; Jun Sang Bae; Kyoung Min Kim; Ho Sung Park; Dong Hyu Cho; Kyu Yun Jang; Woo Sung Moon; Myoung Jae Kang; Dong Geun Lee; Myoung Ja Chung
Journal:  Korean J Pathol       Date:  2012-10-25

6.  Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress.

Authors:  Philip L Marjon; Ekaterina V Bobrovnikova-Marjon; Steve F Abcouwer
Journal:  Mol Cancer       Date:  2004-01-22       Impact factor: 27.401

7.  A human genome-wide library of local phylogeny predictions for whole-genome inference problems.

Authors:  Srinath Sridhar; Russell Schwartz
Journal:  BMC Genomics       Date:  2008-08-18       Impact factor: 3.969

8.  The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma.

Authors:  Yoo Jin Lee; Yu Jin Hah; Yu Jin Ha; Yu Na Kang; Koo Jeong Kang; Jae Seok Hwang; Woo Jin Chung; Kwang Bum Cho; Kyung Sik Park; Eun Soo Kim; Hye-Young Seo; Mi-Kyung Kim; Keun-Gyu Park; Byoung Kuk Jang
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

9.  OSskcm: an online survival analysis webserver for skin cutaneous melanoma based on 1085 transcriptomic profiles.

Authors:  Lu Zhang; Qiang Wang; Lijie Wang; Longxiang Xie; Yang An; Guosen Zhang; Wan Zhu; Yongqiang Li; Zhihui Liu; Xiaochen Zhang; Panpan Tang; Xiaozheng Huo; Xiangqian Guo
Journal:  Cancer Cell Int       Date:  2020-05-19       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.